pharma · Chronic Spontaneous Urticaria (CSU) · Asthma · SPRY
Ars Pharmaceuticals Irl
Ars Pharmaceuticals Irl Limited
Ars Pharmaceuticals Irl clinical programs — 8 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- San Diego, USA
- Employees
- 187
- Programs
- 8
- Drugs
- 7
- Patents
- 0
Ars Pharmaceuticals Irl projects
8 ClinicalTrials.gov programs sponsored by Ars Pharmaceuticals Irl.
Ars Pharmaceuticals Irl has 8 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
SPECT : 123 I-FP-CIT (DATSCAN) and 123I-ADAM
Ars Pharmaceuticals Irl Limited
Amyotrophic Lateral Sclerosis
1 trial -
ARS-1
Ars Pharmaceuticals Irl Limited
Urticaria
1 trial -
ARS-1
Ars Pharmaceuticals Irl Limited
Asthma
1 trial -
EPI-U02
Ars Pharmaceuticals Irl Limited
Chronic Spontaneous Urticaria (CSU)
1 trial -
Placebo
Ars Pharmaceuticals Irl Limited
Urticaria Chronic
1 trial -
ARS-1 with URTI
Ars Pharmaceuticals Irl Limited
Upper Respiratory Tract Infection
1 trial -
IXCHIQ
Ars Pharmaceuticals Irl Limited
Chikungunya Virus Infection
1 trial -
Neffy
Ars Pharmaceuticals Irl Limited
Allergic Reactions
1 trial
Frequently asked questions
How many clinical projects does Ars Pharmaceuticals Irl have?
8 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.